These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. More insight into mesenchymal stem cells and their effects inside the body. Zou Z; Zhang Y; Hao L; Wang F; Liu D; Su Y; Sun H Expert Opin Biol Ther; 2010 Feb; 10(2):215-30. PubMed ID: 20088716 [TBL] [Abstract][Full Text] [Related]
44. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Morigi M; Rota C; Montemurro T; Montelatici E; Lo Cicero V; Imberti B; Abbate M; Zoja C; Cassis P; Longaretti L; Rebulla P; Introna M; Capelli C; Benigni A; Remuzzi G; Lazzari L Stem Cells; 2010 Mar; 28(3):513-22. PubMed ID: 20049901 [TBL] [Abstract][Full Text] [Related]
45. Concise review: the immune status of mesenchymal stem cells and its relevance for therapeutic application. Knaän-Shanzer S Stem Cells; 2014 Mar; 32(3):603-8. PubMed ID: 24123756 [TBL] [Abstract][Full Text] [Related]
46. Mechanisms of and perspectives on the mesenchymal stem cell in immunotherapy. Zhao RC; Liao L; Han Q J Lab Clin Med; 2004 May; 143(5):284-91. PubMed ID: 15122172 [TBL] [Abstract][Full Text] [Related]
47. Adipose tissue-derived mesenchymal stem cells and hepatic differentiation: old concepts and future perspectives. Puglisi MA; Saulnier N; Piscaglia AC; Tondi P; Agnes S; Gasbarrini A Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):355-64. PubMed ID: 21608430 [TBL] [Abstract][Full Text] [Related]
48. The use of stem cells in kidney disease. Chhabra P; Brayman KL Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150 [TBL] [Abstract][Full Text] [Related]
50. PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice. Ni K; Liu M; Zheng J; Wen L; Chen Q; Xiang Z; Lam KT; Liu Y; Chan GC; Lau YL; Tu W Am J Respir Cell Mol Biol; 2018 Jun; 58(6):684-695. PubMed ID: 29220578 [TBL] [Abstract][Full Text] [Related]
51. Mesenchymal stem cells in fibrotic diseases-the two sides of the same coin. Qin L; Liu N; Bao CL; Yang DZ; Ma GX; Yi WH; Xiao GZ; Cao HL Acta Pharmacol Sin; 2023 Feb; 44(2):268-287. PubMed ID: 35896695 [TBL] [Abstract][Full Text] [Related]
52. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. Gharaee-Kermani M; Gyetko MR; Hu B; Phan SH Pharm Res; 2007 May; 24(5):819-41. PubMed ID: 17333393 [TBL] [Abstract][Full Text] [Related]
53. [Perspectives for treatment of pulmonary fibrosis]. Siemińska A Pneumonol Alergol Pol; 1999; 67(11-12):576-82. PubMed ID: 11057110 [TBL] [Abstract][Full Text] [Related]
54. Pulmonary fibrosis: searching for model answers. Chua F; Gauldie J; Laurent GJ Am J Respir Cell Mol Biol; 2005 Jul; 33(1):9-13. PubMed ID: 15964990 [TBL] [Abstract][Full Text] [Related]
55. Mesenchymal Stem Cells and Lung Transplantation: A Couple for a Perfect Relationship. Mohamed MS J Stem Cells; 2015; 10(1):63-7. PubMed ID: 26665938 [TBL] [Abstract][Full Text] [Related]
57. The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis. Zanoni M; Cortesi M; Zamagni A; Tesei A Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398940 [TBL] [Abstract][Full Text] [Related]
58. Mesenchymal stem cells in the treatment of chronic lung disease. Wecht S; Rojas M Respirology; 2016 Nov; 21(8):1366-1375. PubMed ID: 27688156 [TBL] [Abstract][Full Text] [Related]
59. Novel therapeutic strategies for lung disorders associated with airway remodelling and fibrosis. Royce SG; Moodley Y; Samuel CS Pharmacol Ther; 2014 Mar; 141(3):250-60. PubMed ID: 24513131 [TBL] [Abstract][Full Text] [Related]
60. Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: An Update and Concise Review. Chen X; Wang F; Huang Z; Wu Y; Geng J; Wang Y Int J Med Sci; 2021; 18(13):2849-2870. PubMed ID: 34220313 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]